AI assistant
Sending…
ANGIODYNAMICS INC — Director's Dealing 2015
Jul 24, 2015
32939_dirs_2015-07-24_5ea6af00-93bd-4d8e-a51b-ad10ba002e9d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2015-07-22
Reporting Person: DONNELLY HOWARD W (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-07-22 | Common Stock | A | 5266 | — | Acquired | 34925 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-07-22 | Non-Qualified Stock Option (right to buy) | $15.95 | A | 6022 | Acquired | 2022-07-22 | Common Stock (6022) | Direct |
Footnotes
F1: The acquisition of 5,266 shares of common stock represents 5,266 restricted stock units, each of which represents a contingent right to receive one share of AngioDynamics, Inc. common stock. The restricted stock units vest in three equal installments beginning on 07/22/2016.
F2: Options for 33 1/3% of the shares are each exercisable on 07/22/2016, 07/22/2017 and 07/22/2018, respectively.
More from ANGIODYNAMICS INC
Regulatory Filings
2026
Apr 23
Interim / Quarterly Report
2026
Apr 2
Regulatory Filings
2026
Apr 2
Major Shareholding Notification
2026
Mar 26
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Feb 10
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Jan 14
Major Shareholding Notification
2026
Jan 8
Regulatory Filings
2026
Jan 6